- CA$36.50m
- CA$38.75m
- CA$35.34m
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.118 | 0 | 0.342 | 0.842 | 35.3 |
Cost of Revenue | |||||
Gross Profit | — | — | -0.148 | -0.428 | 7.61 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 28.7 | 2.14 | 4.34 | 4.1 | 34.6 |
Operating Profit | -28.6 | -2.14 | -4 | -3.25 | 0.709 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -28.6 | -3.03 | -4.92 | -4.99 | -0.562 |
Provision for Income Taxes | |||||
Net Income After Taxes | -28.6 | -3.03 | -4.92 | -4.99 | -0.914 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -28.5 | -2.82 | -4.56 | -4.73 | -0.914 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -28.5 | -2.82 | -4.56 | -4.73 | -0.914 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.04 | -0.033 | -0.06 | -0.062 | -0.013 |